Statements (23)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:chemical_compound
|
gptkbp:ATCCode |
none
|
gptkbp:CASNumber |
153254-86-1
|
gptkbp:drugClass |
norepinephrine reuptake inhibitor
|
gptkbp:hasInChIKey |
QKJXYYOQSYFJNP-UHFFFAOYSA-N
|
gptkbp:hasMolecularFormula |
C17H19NO3
|
gptkbp:hasResearchUse |
investigational antidepressant
|
gptkbp:hasSMILES |
COC1=CC=CC=C1OCC(CN(C)C)C2=CC=CC=C2
|
gptkbp:hasUNII |
2Z4K3JZ5YK
|
https://www.w3.org/2000/01/rdf-schema#label |
CHEMBL14244
|
gptkbp:isExperimentalDrug |
true
|
gptkbp:IUPACName |
gptkb:(RS)-3-(2-methoxyphenoxy)-N-methyl-3-phenylpropan-1-amine
|
gptkbp:molecularWeight |
285.34
|
gptkbp:PubChem_CID |
gptkb:CHEMBL14244
4437 |
gptkbp:routeOfAdministration |
oral
|
gptkbp:status |
not approved for medical use
|
gptkbp:synonym |
gptkb:Nisoxetine
|
gptkbp:target |
gptkb:norepinephrine_transporter
|
gptkbp:therapeuticArea |
gptkb:depression
gptkb:attention_deficit_hyperactivity_disorder |
gptkbp:bfsParent |
gptkb:nonane
|
gptkbp:bfsLayer |
7
|